| Pharmaceutical Formulations | Finished Dosage Formulations including tablets, capsules, oral liquids, ointments across multiple therapeutic areas including oncology. | EU GMP-certified manufacturing, extensive export network, recognized in oncology segment, and diverse product portfolio. | B2B and B2C customers including hospitals, pharmacies, government projects, and international distributors. | Oncology and specialized therapeutic products carry higher margins. | 163 | 100 | Revenue primarily from product sales to domestic market and exports. | Direct sales and contracts with government and foreign partners; market-driven pricing. | New oncology product launches, international expansion, government tenders, and upgraded manufacturing capacity. | |
